Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Renal Biomarkers in the Early Detection of Acute Kidney Injury After Off-Pump Coronary Artery Bypass Grafting. | Circ J | 2024 | 38008427 | PubTator, text mining | PubMed |
| Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study. | Acta Diabetol | 2024 | 38006524 | PubTator, text mining | PubMed |
| Biomarker array for prediction of acute kidney injury after percutaneous coronary intervention for patients who had acute ST segment elevation myocardial infarction. | Heart Vessels | 2024 | 37957288 | PubTator, text mining | PubMed |
| Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury. | Nephrology (Carlton) | 2024 | 37950597 | PubTator, text mining | PubMed |
| Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study. | Diabetes Ther | 2024 | 37883001 | PubTator, text mining | PubMed |
| Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022. | Clin Exp Nephrol | 2024 | 37878114 | PubTator, text mining | PubMed |
| Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation. | Transplant Cell Ther | 2024 | 37813188 | PubTator, text mining | PubMed |
| A comparative proteomic analysis for non-invasive early prediction of hypoxic-ischemic injury in asphyxiated neonates. | Proteomics Clin Appl | 2024 | 37787895 | PubTator, text mining | PubMed |
| Predictive Performance of Neutrophil Gelatinase Associated Lipocalin, Liver Type Fatty Acid Binding Protein, and Cystatin C for Acute Kidney Injury and Mortality in Severely Ill Patients. | Ann Lab Med | 2024 | 37749888 | PubTator, text mining | PubMed |
| LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemia. | Hepatology | 2024 | 37676481 | PubTator, text mining | PubMed |
| Identification of the novel markers of PPAR signalling affecting immune microenvironment and immunotherapy response of lung adenocarcinoma patients. | J Cell Mol Med | 2024 | 37556076 | PubTator, text mining | PubMed |
| Importance of fatty acid binding proteins in cellular function and organismal metabolism. | J Cell Mol Med | 2024 | 36876733 | PubTator, text mining | PubMed |
| The effect of perioperative AKI on surgical outcomes. | Anesthesiol Perioper Sci | 2023 | 39877395 | PubTator, text mining | PubMed |
| Mass Sportrometry: An annual look back at applications of mass spectrometry in sport and exercise science. | Anal Sci Adv | 2023 | 38715927 | PubTator, text mining | PubMed |
| Development and application of an amplified luminescent proximity homogeneous assay-linked immunosorbent assay for the accurate quantification of kidney injury molecule-1. | Front Mol Biosci | 2023 | 38304229 | PubTator, text mining | PubMed |
| Complexity of human death: its physiological, transcriptomic, and microbiological implications. | Front Microbiol | 2023 | 38282739 | PubTator, text mining | PubMed |
| Potential Biomarkers for the Earlier Diagnosis of Kidney and Liver Damage in Acute Intermittent Porphyria. | Life (Basel) | 2023 | 38276268 | PubTator, text mining | PubMed |
| Chronic Kidney Disease Associated with Ischemic Heart Disease: To What Extent Do Biomarkers Help? | Life (Basel) | 2023 | 38255650 | PubTator, text mining | PubMed |
| The Impact of Biomarkers on the Early Detection of Acute Mesenteric Ischemia. | Biomedicines | 2023 | 38255192 | PubTator, text mining | PubMed |
| Unveiling the Dichotomy of Urinary Proteins: Diagnostic Insights into Breast and Prostate Cancer and Their Roles. | Proteomes | 2023 | 38250812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=14